CRISPR-Based Epigenome Editing Screens in Primary Human T Cells
Publication
, Conference
McCutcheon, S; Amador, CM; Barrera, A; Humayun, L; Gersbach, C
Published in: MOLECULAR THERAPY
2022
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2022
Volume
30
Issue
4
Start / End Page
165 / 166
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
McCutcheon, S., Amador, C. M., Barrera, A., Humayun, L., & Gersbach, C. (2022). CRISPR-Based Epigenome Editing Screens in Primary Human T Cells. In MOLECULAR THERAPY (Vol. 30, pp. 165–166).
McCutcheon, Sean, Christian McRoberts Amador, Alex Barrera, Lucas Humayun, and Charles Gersbach. “CRISPR-Based Epigenome Editing Screens in Primary Human T Cells.” In MOLECULAR THERAPY, 30:165–66, 2022.
McCutcheon S, Amador CM, Barrera A, Humayun L, Gersbach C. CRISPR-Based Epigenome Editing Screens in Primary Human T Cells. In: MOLECULAR THERAPY. 2022. p. 165–6.
McCutcheon, Sean, et al. “CRISPR-Based Epigenome Editing Screens in Primary Human T Cells.” MOLECULAR THERAPY, vol. 30, no. 4, 2022, pp. 165–66.
McCutcheon S, Amador CM, Barrera A, Humayun L, Gersbach C. CRISPR-Based Epigenome Editing Screens in Primary Human T Cells. MOLECULAR THERAPY. 2022. p. 165–166.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2022
Volume
30
Issue
4
Start / End Page
165 / 166
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences